相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors
Alison M. Nagle et al.
CLINICAL CANCER RESEARCH (2018)
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling
Oleksii S. Rukhlenko et al.
CELL SYSTEMS (2018)
Evaluation of Parallel Tempering to Accelerate Bayesian Parameter Estimation in Systems Biology
Sanjana Gupta et al.
2018 26TH EUROMICRO INTERNATIONAL CONFERENCE ON PARALLEL, DISTRIBUTED, AND NETWORK-BASED PROCESSING (PDP 2018) (2018)
Quantitative Systems Pharmacology: A Case for Disease Models
C. J. Musante et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Protein network construction using reverse phase protein array data
Rency S. Varghese et al.
METHODS (2017)
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
Aaron Simpson et al.
TARGETED ONCOLOGY (2017)
Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression
Weikang Cai et al.
NATURE COMMUNICATIONS (2017)
BioNetGen 2.2: advances in rule-based modeling
Leonard A. Harris et al.
BIOINFORMATICS (2016)
Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways
Cemal Erdem et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway
Tujin Shi et al.
SCIENCE SIGNALING (2016)
Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway
Tujin Shi et al.
SCIENCE SIGNALING (2016)
A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine
Andrew M. Stern et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Adiposity and cancer risk: new mechanistic insights from epidemiology
Andrew G. Renehan et al.
NATURE REVIEWS CANCER (2015)
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology (vol 30, pg 142, 2012)
Fortunato Bianconi et al.
BIOTECHNOLOGY ADVANCES (2013)
How insulin engages its primary binding site on the insulin receptor
John G. Menting et al.
NATURE (2013)
MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response
Pawel Kocieniewski et al.
PHYSICAL BIOLOGY (2013)
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
Shan Zhao et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling
Matthew S. Creamer et al.
BMC SYSTEMS BIOLOGY (2012)
Different designs of kinase-phosphatase interactions and phosphatase sequestration shapes the robustness and signal flow in the MAPK cascade
Uddipan Sarma et al.
BMC SYSTEMS BIOLOGY (2012)
RuleBender: a visual interface for rule-based modeling
Wen Xu et al.
BIOINFORMATICS (2011)
The Link between the Metabolic Syndrome and Cancer
Sandra Braun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Signalling by insulin and IGF receptors: supporting acts and new players
Kenneth Siddle
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Peter E. Clayton et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Fine Details of IGF-1R Activation, Inhibition, and Asymmetry Determined by Associated Hydrogen/Deuterium-Exchange and Peptide Mass Mapping
Damian Houde et al.
STRUCTURE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Molecular mechanisms of cancer development in obesity
Melin J. Khandekar et al.
NATURE REVIEWS CANCER (2011)
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
Robert G. Maki
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting Insulin-Like Growth Factor Signaling: Rational Combination Strategies
David Olmos et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The proliferating role of insulin and insulin-like growth factors in cancer
Emily Jane Gallagher et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
Angelo J. Casa et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Dissection of the insulin signaling pathway via quantitative phosphoproteomics
Marcus Krueger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Regulation of apoptosis by insulin-like growth factor (IGF)-I
Ron Kooijman
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Formal molecular biology
V Danos et al.
THEORETICAL COMPUTER SCIENCE (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
Statistical mechanical approaches to models with many poorly known parameters
KS Brown et al.
PHYSICAL REVIEW E (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
A mathematical model of metabolic insulin signaling pathways
AR Sedaghat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors
B Schoeberl et al.
NATURE BIOTECHNOLOGY (2002)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and 1RS-1/Grb-2/Sos complex formation in a breast cancer model
LP Weng et al.
HUMAN MOLECULAR GENETICS (2001)